Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
New Kogenate Storage Guidelines Promise Added Convenience
 

Bayer Biological Products (BP) announced that it received U.S. Food and Drug Administration approval of new storage guidelines for its recombinant factor VIII product, Kogenate FS®. The guidelines, which will appear on all Kogenate FS® packaging starting in November 2005, will allow the product to be stored at room temperature (77 degrees Fahrenheit, 25 degrees Celsius). Although this mode of storage is now an acceptable option, Bayer recommends factor be refrigerated when possible.    

“We are pleased with the approval and the opportunity to provide our customers with this convenience. This new labeling will provide greater freedom and allow individuals with hemophilia A to lead full, active and productive lives,” said Terry Tenbrunsel, vice president of sales and marketing for Bayer BP.

Source: Business Wire, October 6, 2005

 

This section of our Web site is sponsored by: